Glucagon-like peptide-1 derived cardioprotection does not utilize a KATP-channel dependent pathway: mechanistic insights from human supply and demand ischemia studies-Reference-Cited by-同舟云学术

Glucagon-like peptide-1 derived cardioprotection does not utilize a KATP-channel dependent pathway: mechanistic insights from human supply and demand ischemia studies

Published:2016-07-19 Issue:1 Volume:15 Page:
ISSN:1475-2840
Container-title:Cardiovascular Diabetology
language:en
Short-container-title:Cardiovasc Diabetol

Author:

Giblett Joel P.,Axell Richard G.,White Paul A.,Clarke Sophie J.,McCormick Liam,Read Philip A.,Reinhold Johannes,Brown Adam J.,O’Sullivan Michael,West Nick E. J.,Dutka David P.,Hoole Stephen P.

Funder

NIHR Biomedical Research Centre

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1186/s12933-016-0416-3

Reference38 articles.

1. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med. 2007;357(11):1121–35.

2. Giblett JP, West NE, Hoole SP. Cardioprotection for percutaneous coronary intervention—reperfusion quality as well as quantity. Int J Cardiol. 2014;177(3):786–93.

3. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74(5):1124–36.